Giulia Puppo

Papers

Total Citations

H-Index

About

Giulia Puppo is a prominent researcher and advocate in the fields of female sexual health, medical ethics, and gender equity in clinical research. Her most cited work centers on the controversial US Food and Drug Administration (FDA) approval of Addyi (flibanserin) for the treatment of Hypoactive Sexual Desire Disorder (HSDD). In this landmark 2015 paper, Puppo critically analyzed the regulatory and social debates surrounding the approval, highlighting the interplay between pharmaceutical lobbying, definitions of female sexual dysfunction, and standards of evidence. This contribution has been cited 14 times and remains a key reference for scholars examining the politicization of women’s health. Beyond this single paper, Puppo’s broader research challenges long-standing biases in medical literature, particularly regarding the anatomical and physiological understanding of female sexuality. Her work has been instrumental in advocating for more rigorous, gender-sensitive research methodologies. Through her publications and public commentary, Puppo has influenced both academic discourse and clinical practice, making her a vital voice in the ongoing effort to ensure that women’s sexual health is studied and treated with the same scientific rigor as men’s.